NCT06593262

Brief Summary

Insomnia is a common sleep problem, which affects 9.4-38.2% of youths worldwide. Youth insomnia is linked to mental health problems, leading to substantial health and economic burden. The project aims to conduct an assessor-blind, randomized controlled trial to evaluate the efficacy of an app-based CBT-I with AI chatbot in reducing insomnia symptoms among youths, compared to an app-based CBT-I without AI chatbot.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
168

participants targeted

Target at P75+ for not_applicable

Timeline
3mo left

Started Jul 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress91%
Jul 2024Aug 2026

Study Start

First participant enrolled

July 26, 2024

Completed
23 days until next milestone

First Submitted

Initial submission to the registry

August 18, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2026

Last Updated

March 18, 2026

Status Verified

March 1, 2026

Enrollment Period

1.9 years

First QC Date

August 18, 2024

Last Update Submit

March 16, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Insomnia Severity Index

    the severity of insomnia symptoms

    a) baseline; b) interim during intervention (2-week after baseline); c) post-intervention (1-month after baseline); d) 3-month after intervention (4-month after baseline); e) 6-month after intervention (7-month after baseline)

Secondary Outcomes (14)

  • sleep onset latency (SOL)

    a) baseline; c) post-intervention (1-month after baseline); d) 3-month after intervention (4-month after baseline); e) 6-month after intervention (7-month after baseline)

  • wake after sleep onset (WASO)

    a) baseline; c) post-intervention (1-month after baseline); d) 3-month after intervention (4-month after baseline); e) 6-month after intervention (7-month after baseline)

  • sleep efficiency (SE)

    a) baseline; c) post-intervention (1-month after baseline); d) 3-month after intervention (4-month after baseline); e) 6-month after intervention (7-month after baseline)

  • Total sleep time (TST)

    a) baseline; c) post-intervention (1-month after baseline); d) 3-month after intervention (4-month after baseline); e) 6-month after intervention (7-month after baseline)

  • The Pre-Sleep Arousal Scale

    a) baseline; c) post-intervention (1-month after baseline); d) 3-month after intervention (4-month after baseline); e) 6-month after intervention (7-month after baseline)

  • +9 more secondary outcomes

Other Outcomes (4)

  • Treatment Satisfaction Scale

    post-intervention (1-month after baseline)

  • Treatment Component Adherence

    post-intervention (1-month after baseline)

  • Acceptability E-scale questionnaire

    post-intervention (1-month after baseline)

  • +1 more other outcomes

Study Arms (2)

app-based digital cognitive behavioral therapy for insomnia with AI chatbot

EXPERIMENTAL
Behavioral: app-based digital cognitive behavioral therapy for insomnia with AI chatbot

app-based digital cognitive behavioral therapy for insomnia without AI chatbot

ACTIVE COMPARATOR
Behavioral: app-based digital cognitive behavioral therapy for insomnia without AI chatbot

Interventions

digital cognitive behavioral therapy for insomnia with two-way interactive, intelligent, and patient-centered conversational agents

app-based digital cognitive behavioral therapy for insomnia with AI chatbot

digital cognitive behavioral therapy for insomnia without two-way interactive, intelligent, and patient-centered conversational agents

app-based digital cognitive behavioral therapy for insomnia without AI chatbot

Eligibility Criteria

Age18 Years - 25 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • i. Youth aged 18 to 25 years (as defined by WHO and evidence on AI mental health chatbots only available for individuals aged 18 years and older)
  • ii. Online informed consent of participation in the study should be provided
  • iii. Willing to comply with the requirements of the study protocol
  • iv. The presence of moderate to severe insomnia measured by a score of 15 or above on the Insomnia Severity Index (ISI)
  • v. difficulties initiating, maintaining or nonrestorative sleep over a 1-month period
  • vi. Having access to a smartphone and consistent internet access for their smartphone
  • vii. Accepting the terms of service and privacy policies of the mobile apps used in the study for the delivery of the intervention

You may not qualify if:

  • i. A history of any sleep disorder(s) (other than insomnia disorder) such as narcolepsy, obstructive sleep apnea, and restless legs syndrome
  • ii. A history of any mental retardation or neuropsychiatric disorder(s) (other than depression and anxiety disorders as they are the secondary outcomes) such as bipolar disorder, schizophrenia, and substance use disorder
  • iii. Presence of serious suicidality as evidenced by ideation with a plan or an attempt
  • iv. Receiving any pharmacological treatment (including sleep promoting agents)
  • v. Receiving any structured psychotherapy
  • vi. Having shiftwork and trans-meridian travel in the past 3 months and during the intervention

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Psychiatry, the Chinese University of Hong Kong

Hong Kong, Hong Kong

Location

MeSH Terms

Conditions

Sleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof.

Study Record Dates

First Submitted

August 18, 2024

First Posted

September 19, 2024

Study Start

July 26, 2024

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

August 1, 2026

Last Updated

March 18, 2026

Record last verified: 2026-03

Locations